期刊文献+

放射性肺纤维化的分子机制及其防治药物综述 被引量:9

Review on molecular mechanisms and protective drugs research on radiation-induced lung fibrosis
下载PDF
导出
摘要 对放射性肺纤维化(Radiation-induced lung fibrosis,RILF)的发生、发展和最终形成过程中涉及到的细胞、细胞因子、信号通路以及关键因子进行归纳、总结和讨论,并给出具有潜在治疗作用的靶点以及作用在该靶点的相关药物,为今后研发预防与治疗RILF的药物提供思路。 The current understanding of the cells, cytokines, and the key factors linked to the signaling networks implicated in RILF were summarized. Targets with potential therapeutic effects for the treatment of RILF were also be discussed and listed. From all above, we hope to provide researchers with ideas in studying the drugs with prevention and (or) the treatment of RILF.
出处 《辐射研究与辐射工艺学报》 CAS CSCD 2016年第1期1-10,共10页 Journal of Radiation Research and Radiation Processing
基金 北京协和医学院协和青年创新基金(1568) 中国医学科学院放射医学研究所探索基金(1560)资助~~
关键词 放射性肺纤维化 分子机制 细胞因子 防护药物 综述 Radiation-induced lung fibrosis(RILF), Molecular mechanisms, Cytokines, Protective drugs, Review
  • 相关文献

参考文献52

  • 1尹勇,于金明,邢力刚.剂量体积直方图参数评估放射性肺损伤的作用[J].中华肿瘤杂志,2003,25(4):313-315. 被引量:23
  • 2YIN Yong, YU Jinming, XING Ligang. The role of dose volume histogram parameters to assess radiation-induced lung injury [J]. Chinese Journal of Oncology, 2003, 25(04): 1-3.
  • 3Straub J M, New J, Hamilton C D, et al. Radiation-induced fibrosis: mechanisms and implications for therapy [J]. Journal of Cancer Research and Clinical Oncology, 2015, 141(11): 1985-1994.
  • 4Ghafoori P, Marks L B, Vujaskovic Z, et al. Radiation-induced lung injury: assessment, management, and prevention [J]. Oncology, 2008, 22(1): 37-47.
  • 5Zhao W, Robbins M E. Inflammation and chronic oxidative stress in radiation-induced late normal tissue injury: therapeutic implications [J]. Current Medicinal Chemistry, 2009, 16(2): 130-143.
  • 6Trott K R, Herrmann T, Kasper M. Target cells in radiation pneumopathy [J]. International Journal of Radiation Oncology Biology Physics, 2004, 58(2): 463-469.
  • 7Sica A, Mantovani A. Macrophage plasticity and polarization: in vivo veritas [J]. Journal of Clinical Investigation, 2012, 122(3): 787-795. DOI: 10.1172/ JCI59643.
  • 8Varin A, Gordon S. Alternative activation of macrophages: immune function and cellular biology [J]. Immunobiology, 2009, 214(7): 630-641. DOI: 10.1016/j.imbio.2008.11. 009.
  • 9Gordon S, Martinez F O. Alternative activation of macrophages: mechanism and functions [J]. Immunity, 2010, 32(5): 593-604. DOI: 10.1016/j.immuni.2010.05. 007.
  • 10Zhang H, Han Liu H, et al. The development of classically and alternatively activated macrophages has different effects on the varied stages of radiation-induced pulmonary injury in mice [J]. Journal of Radiation Research, 2011, 52(6): 717-726.

二级参考文献43

  • 1王颖杰,王绿化,冯勤付,陈东福,张宏兴,肖泽芬,周宗玫,欧广飞,赵路军,章众,张可,殷蔚伯.肺癌三维适形放射治疗中肺和食管损伤的相关因素分析[J].中国肺癌杂志,2005,8(5):454-458. 被引量:16
  • 2Graham MV. Predicting radiation response, lnt J Radiat Oneol Biol Phys, 1997,39: 561-562.
  • 3Graham MV, Purdy JA, Emami B, et al. Clinical dose-volmne histogram analysis for peneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncel Biol Phys, 1999,45:323-329.
  • 4Marks LB, Spencer DP, Sherouse GW, et al. The role of three dimensional functional lung imaging in radiation treatment planning: the functional dose-volume histogram. Int J Radiat Oncol Biol Phys, 1995,33: 65-75.
  • 5Kwa SIS, Lebesque JV, Thenws JCM, et al. Radiation pneumonitis as a function of mean lung dose: a analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys, 1998,42:1-9.
  • 6Lyman J. Complication probability as assessed from dose-volmne histograms. Radiation Res, 1985,104:13-19.
  • 7Kutcher GJ, Burman C, Brewster L, et al. Historgram reduction method for calctdating complication probabilities for three-dimensional treatment planning evaluations. Int J Radiat Oncol Biol Phys, 1991,21 : 137-146.
  • 8Burman C, Kutcher GJ, Emami B, et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys,1991,21 : 123-135.
  • 9Emani B, Lyman l, Brown A, et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys, 1991,21: 109-122.
  • 10Lyman JT, Wolbrast AB. Optimization of radiation therapy, Ⅲ:a method of assessing complication from dose-volurae histcgrmns. Int J Radiat Oncol Biol Phys, 1987,13:103-109.

共引文献39

同被引文献83

引证文献9

二级引证文献42

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部